Skip to Main Content

Author Details

Patrick W Underwood
College of Medicine, University of Florida
2014
37
14
PMIDPaper TitleJournal TitlePublished Year
36747289Surgical resident experience with common bile duct exploration and assessment of performance and autonomy with formative feedback.World J Emerg Surg2023
37760433Changing Practice Patterns and Improving Survival for Patients with Pancreatic Ductal Adenocarcinoma.Cancers (Basel)2023
37391359A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma.Pancreatology2023
37188579Resource use for cholecystectomy with versus without cholangiography: A multicenter, propensity-matched analysis.Surgery2023
36517292A simulation curriculum for laparoscopic common bile duct exploration, balloon sphincterotomy, and endobiliary stenting: Associations with resident performance and autonomy in the operating room.Surgery2023
36812168Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients.PLoS One2023
34667112Overcoming Gemcitabine Resistance in Pancreatic Cancer Using the BCL-X<sub>L</sub>-Specific Degrader DT2216.Mol Cancer Ther2022
35476525Calcium channel blockers potentiate gemcitabine chemotherapy  in pancreatic cancer.Proc Natl Acad Sci U S A2022
35395492The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma.Neoplasia2022
35155243Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer.Front Oncol2022
35064087XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer.Proc Natl Acad Sci U S A2022
34791809Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.Cancer Med2022
33388244Biliary intervention rates during neoadjuvant therapy for adenocarcinoma of the pancreatic head.HPB (Oxford)2021
33879459Global Phosphoproteomics Reveal CDK Suppression as a Vulnerability to KRas Addiction in Pancreatic Cancer.Clin Cancer Res2021
33503832Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies.Cancers (Basel)2021
34499741It's more than just cancer biology: Health disparities in patients with pancreatic neuroendocrine tumors.J Surg Oncol2021
34336673The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy.Front Oncol2021
32285629Disparities in Pancreatic Ductal Adenocarcinoma-The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes.Cancer Med2020
31672677Protein Signatures and Tissue Diagnosis of Pancreatic Cancer.J Am Coll Surg2020
31903101Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells.J Drug Deliv Sci Technol2020
32024069Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia.Cancers (Basel)2020
32005635From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer.Cytokine Growth Factor Rev2020
33015617Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models.Int J Pharm X2020
32238357Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy.Cancer Res2020
32132110MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.Cancer Res2020
31168443A deeper understanding of the tumor microenvironment in pancreatic cancer: the key to developing effective immunotherapies.Ann Transl Med2019
32055795Pitfalls of minimally invasive pancreatoduodenectomy.Ann Pancreat Cancer2019
31637683Postoperative surgical trainee opioid prescribing practices (POST-OPP): A national survey.J Opioid Manag2019
31227505Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors.Clin Cancer Res2019
31070281The Proteome of Pancreatic Cancer-Derived Exosomes Reveals Signatures Rich in Key Signaling Pathways.Proteomics2019
30513792Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.Int J Mol Sci2018
29937017Postoperative surgical trainee opioid prescribing practices (POST OPP): an institutional study.J Surg Res2018
28758236Morphometric age and survival following kidney transplantation.Clin Transplant2017
26358578Sarcopenia and failure to rescue following liver transplantation.Clin Transplant2015
24666989Variation in ambulatory surgery utilization in Michigan.J Surg Res2014
24617506Cigarette smoking in living kidney donors: donor and recipient outcomes.Clin Transplant2014
25040933Dorsal muscle group area and surgical outcomes in liver transplantation.Clin Transplant2014
  • 1 - 37 of 37

Recommended Authors

Adam C Mueller
Sidney Kimmel Cancer Center at Thomas Jefferson University
Career Start Year 2017
Number of shared co-authors 0
Aaron M Delman
University of Cincinnati College of Medicine
Career Start Year 2017
Number of shared co-authors 0
Ian W Folkert
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 0
Alex B Blair
Johns Hopkins University School of Medicine
Career Start Year 2015
Number of shared co-authors 0
Cheryl Meguid
University of Colorado
Career Start Year 2014
Number of shared co-authors 0
Ashton A Connor
Houston Methodist Hospital
Career Start Year 2012
Number of shared co-authors 0
Gun Ho Jang
Ontario Institute for Cancer Research
Career Start Year 2011
Number of shared co-authors 0
Amber L Johns
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Career Start Year 2009
Number of shared co-authors 0
Ryan J Ellis
Memorial Sloan Kettering Cancer Center
Career Start Year 2008
Number of shared co-authors 0
Patricio M Polanco
University of Texas Southwestern Medical Center
Career Start Year 2006
Number of shared co-authors 1
Florencia McAllister
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Mark E Smolkin
University of Virginia
Career Start Year 2002
Number of shared co-authors 0
Marco Del Chiaro
University of Colorado
Career Start Year 2001
Number of shared co-authors 0
Umesh Bhanot
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Itzhak Avital
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
Timothy B Gardner
Dartmouth-Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 0
Eric A Collisson
University of California san francisco
Career Start Year 1999
Number of shared co-authors 0
Dhiraj Yadav
University of Pittsburgh Medical Center
Career Start Year 1998
Number of shared co-authors 0
Victor M Zaydfudim
Surgical Outcomes Research Center, University of Virginia
Career Start Year 1996
Number of shared co-authors 0
Syed A Ahmad
University of Cincinnati College of Medicine
Career Start Year 1996
Number of shared co-authors 0
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 0
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 1
Kerrington D Smith
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 0
Stephen W Behrman
430482University of Tennessee Health Science Center
Career Start Year 1990
Number of shared co-authors 0
Nathan Bahary
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 0
Martin D McCarter
University of Colorado School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Kevin E Behrns
University of Florida Central Florida USA.
Career Start Year 1989
Number of shared co-authors 6
Andrew M Lowy
University of California San Diego
Career Start Year 1985
Number of shared co-authors 0
Richard D Schulick
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 0

Collaborators

George A Sarosi
University of Florida Health
Co-authored papers 4
Thomas J George
UF Health Cancer Center
Co-authored papers 3
Philip A Efron
University of Florida Health
Co-authored papers 3
Amanda C Filiberto
University of Florida
Co-authored papers 3
Kenneth L Abbott
University of Florida Health
Co-authored papers 3
Tyler J Loftus
University of Florida Health
Co-authored papers 3
Daniel Delitto
Stanford University School of Medicine
Co-authored papers 3
Benjamin Shickel
University of Florida
Co-authored papers 2
Jennifer B Permuth
Moffitt Cancer Center
Co-authored papers 2
Juan C Mira
University of Florida Health
Co-authored papers 2
Srikar Chamala
USC/Children's Hospital Los Angeles Los Angeles California USA.
Co-authored papers 1
Jeremy A Balch
University of Florida Health
Co-authored papers 1
John M Koomen
Co-authored papers 1
Azra Bihorac
University of Florida, Univerzitet u Sarajevu Medicinski Fakultet
Co-authored papers 1
Abhinandan Batra
University of Florida
Co-authored papers 1
Glenn A Walter
College of Medicine, University of Florida
Co-authored papers 1
Gilbert R Upchurch
University of Florida Health
Co-authored papers 1
Molly Q Nyren
College of Medicine, University of Florida Health
Co-authored papers 1
Release 1.2